Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Oct;45(10):3449-52.
doi: 10.1128/JCM.00765-07. Epub 2007 Aug 1.

First isolations of Segniliparus rugosus from patients with cystic fibrosis

Affiliations
Case Reports

First isolations of Segniliparus rugosus from patients with cystic fibrosis

W Ray Butler et al. J Clin Microbiol. 2007 Oct.

Abstract

We report three cases of the new genus Segniliparus isolated from patients with cystic fibrosis. All isolates were unambiguously identified by 16S rRNA gene sequencing as Segniliparus rugosus (GenBank accession no. AY 60892). Drug susceptibility results that may enhance treatment for cystic fibrosis patients with this opportunistic pathogen are presented.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Dendrogram of electrophoretic types showing relationships among the three clinical CF isolates and the four control strains of Segniliparus. See the text for an explanation of assigned numbers.

Similar articles

Cited by

References

    1. Butler, W. R., M. M. Floyd, J. Brown, S. R. Toney, M. Daneshvar, R. C. Cooksey, J. Carr, A. Steigerwalt, and N. Charles. 2005. Novel mycolic acid-containing bacteria in the family Segniliparaceae fam. nov., including the genus Segniliparus gen. nov., with descriptions of Segniliparus rotundus sp. nov., and Segniliparus rugosus sp. nov. Int. J. Syst. Evol. Microbiol. 55:1615-1624. - PubMed
    1. Butler, W. R., and L. S. Guthertz. 2001. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin. Microbiol. Rev. 14:704-726. - PMC - PubMed
    1. CLSI. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. CLSI document M100-S16 (ISBN 1-56238-588-7). CLSI, Wayne, PA.
    1. Griffith, D. E., T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, M. Iseman, K. Olivier, S. Ruoss, C. Fordham von Reyn, R. J. Wallace, Jr., and K. Winthrop on behalf of the ATS Mycobacterial Diseases Subcommittee. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416. - PubMed
    1. NCCLS. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A (ISBN 1-56238-500-3). NCCLS, Wayne, PA. - PubMed

Publication types

LinkOut - more resources